Navigation Links
Combo Therapy Shows Promise in Treating Brain Tumors
Date:1/18/2008

Radiation seeds, chemo wafers slowed disease, boosted survival

FRIDAY, Jan. 18 (HealthDay News) -- Implantation of radioactive seeds and chemotherapy wafers following surgery shows promise in treating malignant brain tumors, a new study finds.

The early-phase clinical trial, led by researchers at The Neuroscience Institute at the University of Cincinnati and University Hospital, included 34 patients who had the combination therapy after surgery to remove recurrent glioblastoma multiforme (GBM).

The study, designed to assess the safety and effectiveness of simultaneous use of radioactive seeds and chemotherapy wafers, found that median patient survival was 69 weeks. Almost 25 percent (eight) of the patients survived two years. Patients with recurrent GBM who receive conventional treatment (chemotherapy) have a median survival of about 26 weeks.

About 25 percent of patients developed brain tissue death, which was treated with surgery or hyperbaric oxygen and did not affect survival. That rate of brain tissue death appeared to be higher than what's seen in patients treated with either seeds or wafers alone.

"Treatment of recurrent GBM presents a major challenge to neurosurgeons and neuro-oncologists," study author Dr. Ronald Warnick, a professor of neurosurgery, said in a prepared statement.

"Glioblastoma is an aggressive, highly malignant tumor with unclear boundaries. Because of its diffuse nature, surgeons are unable to remove it completely, and it regrows in the majority of patients. Our aim is to find a way to keep the infiltrating glioblastoma cells from growing into adjacent, health tissue," he said.

The radiation seeds, each about the size of a grain of rice, deliver radiation to the targeted area for six months. The chemotherapy wafers, which are about the size of a nickel, are placed along the surface of the brain.

Compared with the use of either one alone, the combination of the seeds and wafers appeared to further delay disease progression and increase length of patient survival, Warnick said.

However, he noted that the effectiveness of the combination therapy is not definitive, because this study did not include a control group.

The study was published in the February issue of the Journal of Neurosurgery.

More information

The U.S. National Cancer Institute has more about brain tumors.



-- Robert Preidt



SOURCE: University of Cincinnati, news release, Jan. 18, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Combo Treatment Best for Elderly Lymphoma Patients
2. Combo Therapy Cuts Prostate Cancer Death Rates
3. Drug Combo Halves Death Risk for Severe COPD Patients
4. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
5. New Combo Treatment Extends Kidney Cancer Survival
6. Drug Combo With Antibiotic May Slow MS Progression
7. Combo PET/CT Scan Helps Spot Breast Cancers Spread
8. Drug Combos Effective Against Rheumatoid Arthritis
9. Drug Combo Boosts Multiple Myeloma Survival
10. CPR, Defibrillator Combo Boosts Cardiac Incident Survival
11. Two-Drug Combo Fights Brain Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Combo Therapy Shows Promise in Treating Brain Tumors
(Date:6/24/2017)... ... June 24, 2017 , ... Dr. Mitchell ... Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable routine and ... to the dentist fit into their patients’ busy lifestyles. Dental365 also gladly work ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... By ... earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ... the top 1% of all charities reviewed by Charity Navigator and earns ANRF a ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection ... denied entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger ... six years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State University will host ... , The two-day conference is focused on advancing scientific knowledge about the aggressive ... and eliminating racial breast cancer-related disparities. The conference theme is “Illuminating Actionable Biology.” ...
(Date:6/23/2017)... ... 2017 , ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in ... quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings ... in Denmark in 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... , June 14, 2017  ivWatch LLC, a medical ... of intravenous (IV) therapy, is pleased to announce it ... of Nonsurgical Hospital Supplies and Equipment at the 2017 ... for the medtech industry. The award was presented by ... K. Javits Center in New York ...
(Date:6/11/2017)... 10, 2017  Eli Lilly and Company (NYSE: ... 3 studies of galcanezumab, an investigational treatment for the ... on several key secondary endpoints for galcanezumab compared to ... studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today ... in Boston . ...
(Date:6/8/2017)... June 8, 2017   Responding to Heath Ledger,s ... the death of singer Chris Cornell in May, ... International offers a free online psychiatric drug ... and families about psychotropic drug risks. The ... died from an accidental overdose, has called for tighter rules ...
Breaking Medicine Technology: